InCarda at Sachs Associates Forum
February 25, 2019 – Zurich
At the Sachs Associates Forum in Zurich, InCarda’s Dr. Grace Colón presented a company update to investors where she discussed the clinical challenges of atrial fibrillation and InCarda’s novel approach to treating it called, InRhythm (oral flecainide for inhalation).
Sachs Associates is a long established international conference company with offices in Switzerland and the UK. It runs a limited number of high profile conferences in Europe and the USA which are focused on biopharma, medtech, and digital health. These conferences focus on licensing and investment opportunities.